Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury. | Int Braz J Urol;47(3): 690-691, 2021. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury.

Kow, Chia Siang; Hasan, Syed Shahzad.

Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
Hasan SS; Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom.

Int Braz J Urol ; 47(3): 690-691, 2021.

Article in English | MEDLINE | ID: covidwho-1097230

Subject(s)

Acute Kidney Injury; COVID-19; Acute Kidney Injury/chemically induced; Acute Kidney Injury/drug therapy; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / COVID-19 Limits: Humans Language: English Journal: Int Braz J Urol Journal subject: Urology Year: 2021 Document Type: Article Affiliation country: S1677-5538.Ibju.2020.1039

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / COVID-19 Limits: Humans Language: English Journal: Int Braz J Urol Journal subject: Urology Year: 2021 Document Type: Article Affiliation country: S1677-5538.Ibju.2020.1039